Ownership Submission
FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Kong Garheng
2. Date of Event Requiring Statement (Month/Day/Year)
10/02/2012
3. Issuer Name and Ticker or Trading Symbol
ALIMERA SCIENCES INC [ALIM]
(Last)
(First)
(Middle)
2800 SAND HILL ROAD, SUITE 150
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

MENLO PARK, CA 94025
6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Series A Convertible Preferred Stock 10/02/2012   (1) Common Stock 3,164,557 (2) $ 3.16 (3) (4) I See footnote (5)
Series A Convertible Preferred Stock Warrant (Right to Buy) 10/02/2012   (6) Series A Convertible Preferred Stock (7) 75,000 $ 44 I See footnote (5)

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Kong Garheng
2800 SAND HILL ROAD
SUITE 150
MENLO PARK, CA 94025
  X   X    
Sofinnova Venture Partners VIII, L.P.
2800 SAND HILL ROAD
SUITE 150
MENLO PARK, CA 94025
    X    
Sofinnova Management VIII, L.L.C.
2800 SAND HILL ROAD
SUITE 150
MENLO PARK, CA 94025
    X    
POWELL MICHAEL
2800 SAND HILL ROAD
SUITE 150
MENLO PARK, CA 94025
    X    
HEALY JAMES
2800 SAND HILL ROAD
SUITE 150
MENLO PARK, CA 94025
    X    

Signatures

/s/ Nathalie Auber, attorney-in-fact for Garheng Kong 10/03/2012
**Signature of Reporting Person Date

/s/ Nathalie Auber, attorney-in-fact for Sofinnova Venture Partners VIII, L.P. 10/03/2012
**Signature of Reporting Person Date

/s/ Nathalie Auber, attorney-in-fact for Sofinnova Management VIII, L.L.C. 10/03/2012
**Signature of Reporting Person Date

/s/ Nathalie Auber, attorney-in-fact for Michael F. Powell 10/03/2012
**Signature of Reporting Person Date

/s/ Nathalie Auber, attorney-in-fact for James I. Healy 10/03/2012
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The Series A Convertible Preferred Stock (the "Series A Preferred Stock") has no expiration date.
(2) The number of underlying shares of common stock is based on a conversion price of $3.16, which is the conversion price for any voluntary conversion of the Series A Preferred Stock at any time prior to the earlier of July 1, 2013 and the determination of the Final Guidance Price (as defined below).
(3) Each share of Series A Preferred Stock is convertible into shares of the Issuer's common stock at any time at the option of the holder at the rate equal to $40.00 divided by the then current conversion price. The Series A Preferred Stock is not convertible at the option of the Issuer. The conversion price of the Series A Preferred Stock is subject to adjustment from $2.91 to $2.66 or $3.16 based on the occurrence or non-occurrence of certain events, in addition to certain customary price based anti-dilution adjustments. Any voluntary conversion of the Series A Preferred Stock into common stock at any time prior to the earlier of July 1, 2013 and the adjustment to either $2.66 or $3.16 (as so adjusted, the "Final Guidance Price") shall be at a conversion price of $3.16 (as adjusted for any price-based anti-dilution). (Continued in footnote 4)
(4) Each share of Series A Preferred Stock shall automatically be converted into shares of the Issuer's common stock upon the occurrence of certain events. The dollar amounts set forth above are subject to adjustment for stock splits, combinations, stock dividends, recapitalizations and the like with respect to the Series A Preferred Stock. For further information on the details regarding the conversion of the Series A Preferred Stock, see the terms of the Certificate of Designation of the Series A Convertible Preferred Stock of the Issuer (attached as Exhibit 3.5 to Form 8-K filed with the Securities and Exchange Commission by the Issuer on October 2, 2012).
(5) The securities are owned directly by Sofinnova Venture Partners VIII, L.P. ("SVP VIII"). Sofinnova Management VIII, L.L.C. ("SM VIII"), the general partner of SVP VIII, and Garheng Kong, a director of the Issuer, Michael Powell, and James I. Healy, the managing members of SM VIII, may be deemed to have shared voting and dispositive power over the shares owned by SVP VIII. Such persons and entities disclaim beneficial ownership over the shares owned by SVP VIII except to the extent of any pecuniary interest therein.
(6) The warrants will expire on the earlier to occur of (i) immediately following the consummation of a sale of the Issuer (for cash or freely tradable securities), if the warrants are not exercised or exchanged at or prior to the consummation of such sale or (ii) October 2, 2017.
(7) At the election of SVP VIII, the warrants may be exercised for the number of shares of common stock then issuable upon conversion of the Series A Preferred Stock that would otherwise be issued upon such exercise at the then-effective conversion price.
 
Remarks:
Exhibit List

Exhibit 24 - Power of Attorney

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.